SFX by Ex Libris Inc.

Title:	Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase
Source:	Nature [0028-0836] Petzold, G yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Fischer, Eric S. "Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide." Nature 512.7512 (2014): 49-53.
description	2.	Krönke, J. "Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells." Science 343.6168 (2013): 301-305.
description	3.	Lingaraju, A. "Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosome." Nature 531.7596 (2016): 598-603.
description	4.	Ito, T. "Myeloid disease: Another action of a thalidomide derivative." Nature 523.7559 (2015): 167-168.
description	5.	Sircar, A. "A generalized approach to sampling backbone conformations with RosettaDock for CAPRI rounds 13-19." Proteins 78.15 (2010): 3115-3123.
description	6.	Lu, G. "The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins." Science 343.6168 (2013): 305-309.
description	7.	Krönke, J. "Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS." Nature 523.7559 (2015): 183-8.
description	8.	Chick, Joel M. "Defining the consequences of genetic variation on a proteome-wide scale." Nature 534.7608 (2016): 500-505.
description	9.	Dixson, Danielle L. "Odor tracking in sharks is reduced under future ocean acidification conditions." Global change biology 21.4 (2014): 1454-1462.
description	10.	Zhu, Yuan X. "Molecular mechanism of action of the immune-modulatory drugs, thalidomide, lenalidomide and pomalidomide in multiple myeloma." Leukemia & lymphoma 54.4 (2012): 683-7.
description	11.	Fischer, Eric S. "SPLINTS: small-molecule protein ligand interface stabilizers." Current opinion in structural biology 37 (2016): 115-122.
description	12.	Ohno, A. "Structural analysis of the TKB domain of ubiquitin ligase Cbl-b complexed with its small inhibitory peptide, Cblin." Archives of biochemistry and biophysics 594 (2016): 1-7.
description	13.	Stathis, A. "Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628." Cancer discovery 6.5 (2016): 492-500.
description	14.	Allison, Timothy M. "Quantifying the stabilizing effects of protein-ligand interactions in the gas phase." Nature Communications 6 (2015): 8551-8551.
description	15.	Emanuel, M. "Thalidomide and its sequelae." Lancet 380.9844 (2012): 781-783.
description	16.	Adamson, B. "A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response." Nature Cell Biology 14.3 (2012): 318-328.
description	17.	Ebert, B. "Mutations in RNA splicing machinery in human cancers." The New England journal of medicine 365.26 (2011): 2534-2535.
description	18.	Singhal, S. "Antitumor activity of thalidomide in refractory multiple myeloma." New England Journal of Medicine, The 341.21 (1999): 1565-1571.
description	19.	Nagelkerken, I. "Ocean acidification and global warming impair shark hunting behaviour and growth." Scientific Reports 5.1 (2015): 16293-16293.
description	20.	Ito, T. "Identification of a primary target of thalidomide teratogenicity." Science 327.5971 (2010): 1345-1350.